CAS 2765082-12-8

RMC-7977

CAS: 2765082-12-8

(1α,5α,6α)-N-[(2R,14S,18S)-2-[5-(4-Cyclopropyl-1-piperazinyl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-1-ethyl-18,19,20,21-tetrahydro-25,25-dimethyl-15,22-dioxo-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl]-3-oxabicyclo[3.1.0]hexane-6-carboxamide

Formel: C₄₇H₆₀N₈O₆S

Reinheit: 98%

Molekulargewicht: 865.09

Ref: IN-DG02525391

RMC-7977

CAS: 2765082-12-8

RMC-7977 is a inhibitor of the active (GTP-bound) forms of KRAS, HRAS, and NRAS with anticancer activity for the study of solid tumors with KRAS G12C mutations.

Formel: C₄₇H₆₀N₈O₆S

Reinheit: 97.11% - 99.86%

Farbe und Form: Solid

Molekulargewicht: 865.09

Ref: TM-T81263

RMC-7977

CAS: 2765082-12-8

RMC-7977

Formel: C₄₇H₆₀N₈O₆S

Reinheit: ≥95%

Molekulargewicht: 865.114

Ref: 54-BUP11451